Table 3 Characteristics of target population associated with exposure to the main intervention components: Assessment of lifestyles (A1), Advice on lifestyle change (A2), and Prescription of lifestyle change (A4)
Variables | Adjusted Hazard Ratio (95% CI) | ||||
|---|---|---|---|---|---|
Assessed (A1) | Advised (A2) | Prescribed (A4) | |||
Age (unit = 5 years) | 1.05 (1.04–1.06) | 1.04 (1.03–1.05) | 1.04 (1.02–1.06) | ||
Sex | Female | 1.00 | 1.00 | 1.00 | |
Male | 0.83 (0.80–0.86) | 0.84 (0.80–0.88) | 0.68 (0.63–0.74) | ||
Cardiovascular disease | No | 1.00 | 1.00 | 1.00 | |
Yes | 1.41 (1.33–1.49) | 1.51 (1.42–1.62) | 1.87 (1.67–2.09) | ||
Musculoskeletal disorder | No | 1.00 | 1.00 | 1.00 | |
Yes | 1.19 (1.11–1.28) | 1.15 (1.05–1.25) | 1.20 (1.04–1.39) | ||
Mental health problem | No | 1.00 | 1.00 | 1.00 | |
Yes | 1.09 (1.04–1.14) | 1.18 (1.11–1.25) | 1.15 (1.03–1.28) | ||
Respiratory disease | No | 1.00 | 1.00 | 1.00 | |
Yes | 1.25 (1.15–1.35) | 1.36 (1.24–1.49) | 1.51 (1.29–1.77) | ||
Digestive disease | No | 1.00 | 1.00 | 1.00 | |
Yes | 1.12 (1.03–1.23) | 1.12 (1.01–1.24) | 1.25 (1.06–1.49) | ||
Metabolism-related disease | No | 1.00 | 1.00 | 1.00 | |
Yes | 1.25 (1.17–1.34) | 1.26 (1.16–1.36) | 1.32 (1.16–1.51) | ||
Other chronic health problem | No | 1.00 | 1.00 | -- | |
Yes | 1.13 (1.05–1.21) | 1.14 (1.05–1.24) | -- | ||
Deprivation Index | High | 1.00 | 1.00 | 1.00 | |
Medium | 1.18 (1.10–1.27) | 1.17 (1.10–1.25) | 1.14 (0.98–1.33) | ||
Low | 1.16 (1.10–1.22) | 1.19 (1.11–1.27) | 1.25 (1.11–1.42) | ||
Center | Center 1 | 1.00 | 1.00 | 1.00 | |
0–3 months | Center 2 | 3.42 (3.00–3.90) | 4.23 (3.47–5.16) | 3.24 (2.47–4.25) | |
Center 3 | 8.54 (7.54–9.66) | 5.04 (4.07–6.25) | 2.06 (1.46–2.89) | ||
Center 4 | 6.19 (5.48–7.00) | 4.54 (3.70–5.56) | 4.22 (3.25–5.47) | ||
3–6 months | Center 2 | 2.97 (2.52–3.48) | 7.43 (5.77–9.56) | 2.62 (1.78–3.88) | |
Center 3 | 3.55 (2.93–4.30) | 6.91 (5.22–9.15) | 6.55 (4.57–9.38) | ||
Center 4 | 8.96 (7.78–10.32) | 10.59 (8.27–13.57) | 6.38 (4.54–8.97) | ||
6–12 months | Center 2 | 4.42 (4.02–4.85) | 2.81 (2.49–3.18) | 0.95 (0.73–1.23) | |
Center 3 | 2.37 (2.08–2.70) | 1.43 (1.20–1.69) | 2.16 (1.71–2.73) | ||
Center 4 | 5.69 (5.17–6.27) | 4.45 (3.97–4.99) | 2.03 (1.64–2.52) | ||
12–24 months | Center 2 | 1.01 (0.92–1.12) | 1.52 (1.37–1.68) | 0.41 (0.32–0.53) | |
Center 3 | 1.26 (1.12–1.42) | 1.01 (0.89–1.15) | 1.24 (1.01–1.52) | ||
Center 4 | 2.50 (2.27–2.75) | 2.91 (2.65–3.19) | 0.91 (0.75–1.11) | ||